Rockefeller Capital Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.38K Hold
201
﹤0.01% 4323
2025
Q4
$3.23K Sell
201
-406
-67% -$6.04K ﹤0.01% 4193
2025
Q3
$7.5K Buy
+607
New +$7.12K ﹤0.01% 3755
2023
Q1
Sell
-564
Closed -$11K 2307
2022
Q4
$11K Sell
564
-7
-1% -$136 ﹤0.01% 3032
2022
Q3
$7K Sell
571
-1,155
-67% -$19.5K ﹤0.01% 3218
2022
Q2
$34K Buy
1,726
+1,279
+286% +$34K ﹤0.01% 2459
2022
Q1
$14K Buy
447
+7
+2% +$196 ﹤0.01% 2878
2021
Q4
$9K Sell
440
-939
-68% -$24.5K ﹤0.01% 3010
2021
Q3
$38K Sell
1,379
-800
-37% -$24.4K ﹤0.01% 2266
2021
Q2
$84K Buy
2,179
+119
+6% +$4.27K ﹤0.01% 1866
2021
Q1
$59K Buy
2,060
+332
+19% +$11.3K ﹤0.01% 1823
2020
Q4
$45K Buy
1,728
+1,279
+285% +$26.1K ﹤0.01% 1714
2020
Q3
$6K Hold
449
﹤0.01% 2146
2020
Q2
$9K Hold
449
﹤0.01% 1916
2020
Q1
$5K Hold
449
﹤0.01% 1936
2019
Q4
$17K Buy
449
+9
+2% +$404 ﹤0.01% 1445
2019
Q3
$21K Hold
440
﹤0.01% 1205
2019
Q2
$23K Sell
440
-188
-30% -$11K ﹤0.01% 986
2019
Q1
$43K Buy
+628
New +$42.1K ﹤0.01% 960

Other funds holding CLB

Rockefeller Capital Management's CLB Position: Q1 2026 in Review

Rockefeller Capital Management held its Core Laboratories (CLB) position steady in Q1 2026 at 201 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4323.

Rockefeller Capital Management first reported a position in CLB in Q1 2019 and has held it in 19 quarters since. The position peaked at $84K in Q2 2021. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Rockefeller Capital Management held 201 shares of Core Laboratories worth $3.38K as of Q1 2026.
  • Rockefeller Capital Management left its Core Laboratories share count unchanged in Q1 2026.
  • Core Laboratories made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4323 holding.
  • Rockefeller Capital Management first reported a position in Core Laboratories in Q1 2019 and has held it in 19 quarters since.
  • Rockefeller Capital Management's Core Laboratories position peaked at $84K in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.